This 5-minute microlearning reinforces the importance of RSV protection for infants born in January–March. With RSV still circulating well into the spring, late-season newborns remain vulnerable. The session provides practical strategies and caregiver communication tips to ensure timely administration of nirsevimab and emphasizes that the season isn’t over until every infant is protected.
This program has received an unrestricted educational grant or in-kind support from Sanofi Canada.